4-39299985-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002913.5(RFC1):c.2808+36C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.447 in 1,211,812 control chromosomes in the GnomAD database, including 125,436 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.51 ( 21680 hom., cov: 33)
Exomes 𝑓: 0.44 ( 103756 hom. )
Consequence
RFC1
NM_002913.5 intron
NM_002913.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.21
Genes affected
RFC1 (HGNC:9969): (replication factor C subunit 1) This gene encodes the large subunit of replication factor C, a five subunit DNA polymerase accessory protein, which is a DNA-dependent ATPase required for eukaryotic DNA replication and repair. The large subunit acts as an activator of DNA polymerases, binds to the 3' end of primers, and promotes coordinated synthesis of both strands. It may also have a role in telomere stability. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 4-39299985-G-C is Benign according to our data. Variant chr4-39299985-G-C is described in ClinVar as [Benign]. Clinvar id is 1327948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.735 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFC1 | NM_002913.5 | c.2808+36C>G | intron_variant | ENST00000349703.7 | NP_002904.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFC1 | ENST00000349703.7 | c.2808+36C>G | intron_variant | 1 | NM_002913.5 | ENSP00000261424 | P4 | |||
RFC1 | ENST00000381897.5 | c.2811+36C>G | intron_variant | 1 | ENSP00000371321 | A2 |
Frequencies
GnomAD3 genomes AF: 0.512 AC: 77788AN: 152034Hom.: 21640 Cov.: 33
GnomAD3 genomes
AF:
AC:
77788
AN:
152034
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.433 AC: 106256AN: 245524Hom.: 24106 AF XY: 0.429 AC XY: 56897AN XY: 132758
GnomAD3 exomes
AF:
AC:
106256
AN:
245524
Hom.:
AF XY:
AC XY:
56897
AN XY:
132758
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.438 AC: 463743AN: 1059660Hom.: 103756 Cov.: 14 AF XY: 0.435 AC XY: 237170AN XY: 545288
GnomAD4 exome
AF:
AC:
463743
AN:
1059660
Hom.:
Cov.:
14
AF XY:
AC XY:
237170
AN XY:
545288
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.512 AC: 77882AN: 152152Hom.: 21680 Cov.: 33 AF XY: 0.507 AC XY: 37686AN XY: 74352
GnomAD4 genome
AF:
AC:
77882
AN:
152152
Hom.:
Cov.:
33
AF XY:
AC XY:
37686
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1436
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at